September 24, 2021

Around the nation: CDC releases new resources to help recognize MIS-C in children

Daily Briefing

    CDC this week released new resources to help identify multisystem inflammatory syndrome in children, a rare but serious immune response linked to Covid-19, in today's bite-sized hospital and health industry news from the District of Columbia, Georgia, and Illinois.

    • District of Columbia: President Joe Biden on Wednesday announced the formation of a new science advisory panel, known as the President’s Council of Advisors on Science and Technology (PCAST). The advisory panel will consist of 30 scientific advisors from a diverse set of backgrounds—including agriculture, biochemistry computer engineering, ecology, nanotechnology, and neuroscience. The panel will advise the White House on a range of global challenges, including climate change and future pandemics. (Stolberg, New York Times, 9/22)
    • Georgia: CDC on Monday released resources to help clinicians identify multisystem inflammatory syndrome in children (MIS-C) and discuss diagnoses with parents of affected children. If symptoms of MIS-C—including ongoing fever, stomach pain, diarrhea, vomiting, skin rash, bloodshot eyes, and dizziness or lightheadedness—appear within six weeks after Covid-19 infection, providers can conduct several tests to identify the disease—including blood tests, chest X-rays, heart ultrasound, and abdominal ultrasound. (Masson, Becker's Hospital Review, 9/22)
    • Illinois: Over the past decade, physicians have prescribed 44% less opioids—but both fatal and nonfatal drug overdoses have continued to increase, according to a new American Medical Association (AMA) report. In response to the alarming overdose statistic, AMA called on lawmakers to "act now" and help provide access to "affordable, evidence-based care for patients with pain." (Coleman, The Hill, 9/21)

    Have a Question?


    Ask our experts a question on any topic in health care by visiting our member portal, AskAdvisory.

    Cookies help us improve your website experience. By using our website, you agree to our use of cookies.